Female Infertility Market Segmentation:
- By Product & Services
- Equipment
- Media & Consumables
- Services
- By Procedure
- Assisted Reproductive Technology (ART)
- Diagnostic Tests
- By End User
- Fertility Clinics
- Hospitals and Research Laboratories
- Cryobanks
- By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of the Middle East
- North America
Frequently Asked Questions
The current market size of the female infertility industry is US$ 19.4 billion in 2023.
Rising rates of infertility globally, Delayed pregnancies and advanced maternal age, Changing lifestyles and rise of reproductive disorders
High cost, low awareness in developing countries, risks involved in ART procedures, restrictive regulations, lack of insurance coverage, social stigma, limited funding and reimbursements.
The media and consumables segment (used in IVF and fertility treatments).
CooperSurgical, Cook Medical, Vitrolife, Thermo Fisher Scientific, Esco Micro, Genea Biomedx, FUJIFILM Irvine Scientific, IVFtech, Kitazato, Rocket Medical are the major players.
The Female Infertility Market is expected to grow at a CAGR of 6.1% from US$ 19.4 billion in 2022 to US$ 29.3 billion by 2030.
Rising infertility rates, delayed pregnancies, favorable government initiatives, emerging treatments like IVF, and increasing cases of lifestyle disorders leading to infertility.